Press Release June 24, 2021FDA accepts application for Roche's Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD) 0 0 Share
Company Ticker News June 22, 2021Roche's Alzheimer's Antibody Reduces Associated Biomarkers In Subset Of AD Patients, Study Shows 0 0 Share
Company Ticker News June 22, 2021Is There More Room For Growth In Roche Stock After A 12% Rise In A Month? 0 0 Share
Company Ticker News June 20, 2021Alzheimer's Approval Validates Biopharmaceutical Innovation 0 0 Share
Press Release June 20, 2021Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care 0 0 Share
Company Ticker News June 20, 2021Roche's New COVID-19 Point Of Care Test Scores FDA Emergency Use Nod 0 0 Share
Company Ticker News June 17, 2021Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy 0 0 Share
